Fail Early, Fail Fast – And Increase Likelihood-of-Approval

Feb 10, 2017 | News

What is this saying “Fail Early, Fail Fast” all about? Is there any merit to it and how is this changing the game for all pharmaceutical drug development companies? Here we will give our thoughts and opinions into how this really carries over to the real world and how...

Amplion Teams with Built Oregon to Publish First Podcast

Jun 30, 2016 | News

The team at Amplion, inventors of BiomarkerBase, is proud to share a podcast we did with Making Oregon – the podcast that brings conversations with innovators, makers, doers, disruptors, and groundbreakers across the state. Take a listen to the story behind...

Cancer Drugs Are The Least Likely to Receive FDA Approval

May 26, 2016 | News

This article was originally published on Fortune.com, by Sy Mukherjee May 26, 2016. But there’s good reason to hope that may change very soon. This post was corrected/updated on Monday, May 30. A massive new study of drug candidates sheds light on which experimental...